Increased Persistency in Medication Use by U.S. Medicare Beneficiaries With Diabetes Is Associated With Lower Hospitalization Rates and Cost Savings
Open Access
- 26 January 2009
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (4), 647-649
- https://doi.org/10.2337/dc08-1311
Abstract
OBJECTIVE: To assess the relationship between annual fills for antidiabetes medications, ACE inhibitors, angiotensin II receptor blockers (ARBs), and lipid-lowering agents on hospitalization and Medicare spending for beneficiaries with diabetes. RESEARCH DESIGN AND METHODS: Using Medicare Current Beneficiary Survey data from 1997 to 2004, we identified 7,441 community-dwelling beneficiaries with diabetes, who contributed 14,317 person-years of data for the analysis. We used multivariate regression analysis to estimate the effect of persistency in medication fills on hospitalization risk, hospital days, and Medicare spending. RESULTS: For users of older oral antidiabetes agents, ACE inhibitors, ARBs, and statins, each additional prescription fill was associated with significantly lower risk of hospitalization, fewer hospital days, and lower Medicare spending. CONCLUSIONS: These results suggest an economic case for promoting greater persistency in use of drugs with approved indications by Medicare beneficiaries with diabetes; however, additional research is needed to corroborate the study's cross-sectional findings.Keywords
This publication has 12 references indexed in Scilit:
- Economic Costs of Diabetes in the U.S. in 2007Diabetes Care, 2008
- Standards of Medical Care in Diabetes—2008Diabetes Care, 2008
- Relationship of Oral Antihyperglycemic (Sulfonylurea or Metformin) Medication Adherence and Hemoglobin A1c Goal Attainment for HMO Patients Enrolled in a Diabetes Disease Management ProgramJournal of Managed Care Pharmacy, 2006
- Unintended Consequences of Caps on Medicare Drug BenefitsNew England Journal of Medicine, 2006
- Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with DiabetesAnnals of Internal Medicine, 2005
- Predictors of Health Care Costs in Adults With DiabetesDiabetes Care, 2005
- Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey dataAnnals of Epidemiology, 2004
- Too much ado about two-part models and transformation?: Comparing methods of modeling Medicare expendituresJournal of Health Economics, 2004
- Economic Costs of Diabetes in the U.S. in 2002Diabetes Care, 2003
- Identifying Persons with Diabetes Using Medicare Claims DataAmerican Journal of Medical Quality, 1999